- Development and optimisation of bioprocesses.
- Cell culture, hESC and iPSC, microalgae, plant cells.
- Production of recombinant proteins, monoclonal antibodies and vaccine candidates.
- Design of bioreactors and single-use elements.
Activatable Antibodies to Increase Selectivity for Brain Tumour Therapies
In the Materials Engineering Group (GEMAT) at the IQS School of Engineering, the team led by Dr Benjami Oller Salvia is working to take on two of the great challenges with GBM therapies.READ FULL NEW